Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert B MacArthur

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Cerebrovascular Diseases (Basel, Switzerland)|July 18, 2009
High-dose lovastatin for acute ischemic stroke: results of the phase I dose escalation neuroprotection with statin therapy for acute recovery trial (NeuSTART)Mitchell S V Elkind, Ralph L Sacco, Robert B Macarthur, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|August 19, 2008
The Neuroprotection with Statin Therapy for Acute Recovery Trial (NeuSTART): an adaptive design phase I dose-escalation study of high-dose lovastatin in acute ischemic strokeMitchell S V Elkind, Ralph L Sacco, Robert B MacArthur, et al.
Neurosurgery|December 29, 2007
O-desulfated heparin improves outcome after rat cerebral ischemia/reperfusion injuryJ Mocco, Corbett E Shelton, Paulina Sergot, et al.
American Journal of Physiology. Cell Physiology|April 9, 2010
Low anticoagulant heparin targets multiple sites of inflammation, suppresses heparin-induced thrombocytopenia, and inhibits interaction of RAGE with its ligandsNarayanam V Rao, Brian Argyle, Xiaoyu Xu, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 2, 2025
Mass balance and metabolite profiling of <sup>14</sup>C-Zalunfiban in humans following single-dose subcutaneous administrationRobert B MacArthur, Sem A O F Rikken, Spandana R Vootukuri, et al.
Journal of Clinical and Translational Science|May 30, 2023
Building an infrastructure to support the development, conduct, and reporting of informative clinical studies: The Rockefeller University experienceRhonda G Kost, Rita K Devine, Mark Fernands, et al.
Plos One|May 29, 2015
A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory NeuroblastomaGiselle L Saulnier Sholler, Eugene W Gerner, Genevieve Bergendahl, et al.
The Lancet. Neurology|November 6, 2007
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trialPaul H Gordon, Dan H Moore, Robert G Miller, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|July 9, 2008
A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALSPaul H Gordon, Ying-Kuen Cheung, Bruce Levin, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cerebrovascular Diseases (Basel, Switzerland)|July 18, 2009
High-dose lovastatin for acute ischemic stroke: results of the phase I dose escalation neuroprotection with statin therapy for acute recovery trial (NeuSTART)Mitchell S V Elkind, Ralph L Sacco, Robert B Macarthur, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|August 19, 2008
The Neuroprotection with Statin Therapy for Acute Recovery Trial (NeuSTART): an adaptive design phase I dose-escalation study of high-dose lovastatin in acute ischemic strokeMitchell S V Elkind, Ralph L Sacco, Robert B MacArthur, et al.
Neurosurgery|December 29, 2007
O-desulfated heparin improves outcome after rat cerebral ischemia/reperfusion injuryJ Mocco, Corbett E Shelton, Paulina Sergot, et al.
American Journal of Physiology. Cell Physiology|April 9, 2010
Low anticoagulant heparin targets multiple sites of inflammation, suppresses heparin-induced thrombocytopenia, and inhibits interaction of RAGE with its ligandsNarayanam V Rao, Brian Argyle, Xiaoyu Xu, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 2, 2025
Mass balance and metabolite profiling of <sup>14</sup>C-Zalunfiban in humans following single-dose subcutaneous administrationRobert B MacArthur, Sem A O F Rikken, Spandana R Vootukuri, et al.
Journal of Clinical and Translational Science|May 30, 2023
Building an infrastructure to support the development, conduct, and reporting of informative clinical studies: The Rockefeller University experienceRhonda G Kost, Rita K Devine, Mark Fernands, et al.
Plos One|May 29, 2015
A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory NeuroblastomaGiselle L Saulnier Sholler, Eugene W Gerner, Genevieve Bergendahl, et al.
The Lancet. Neurology|November 6, 2007
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trialPaul H Gordon, Dan H Moore, Robert G Miller, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|July 9, 2008
A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALSPaul H Gordon, Ying-Kuen Cheung, Bruce Levin, et al.
Pageof 2